Statistical evaluation of the immunohistochemical staining showed that the expression level of PRDM4 was significantly associated with clinical stage and LN metastasis (p < 0.05) but was not associated with age, tumor size, or histological grade (Table 1). This evidence concerns the gene PRDM4 and neoplasm.